Clinical Trials Directory

Trials / Completed

CompletedNCT00605605

Vascular Endothelial Protection Effects of Dextromethorphan

Anti-Inflammation & Vascular Endothelial Protection Effects of Dextromethorphan on Heavy Smoker

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
National Cheng-Kung University Hospital · Academic / Other
Sex
Male
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

To test the hypothesis that DM could have anti-inflammatory effect and thus achieve vascular protection effect on heavy smokers.

Detailed description

Dextromethorphan (DM), an ingredient widely used in antitussive remedies, had been reported to reduce the inflammation-mediated degeneration of neurons. We recently found that DM can prevent vascular remodeling and neuron injury in animal models of carotid ligation and cerebral ischemia injuries, respectively. It was believed that its action was through the anti-oxidant and NADPH pathway to protect brain cells. However, the mechanism and actual effect on human vascular protection remained unclear. To test the hypothesis that DM could have anti-inflammatory effect and thus achieve vascular protection effect on heavy smokers, this prospective study will be conducted to treat subjects with heavy smoking history with DM or not and evaluate the anti-inflammatory and the improvement of endothelial function.

Conditions

Interventions

TypeNameDescription
DRUGDextromethorphan120 mg/day, single once daily dose taken after breakfast by oral route

Timeline

Start date
2005-03-01
Primary completion
2005-12-01
Completion
2005-12-01
First posted
2008-01-31
Last updated
2008-01-31

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00605605. Inclusion in this directory is not an endorsement.